Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Exagamglogene Autotemcel in Anemia, Sickle Cell: NCT05951205 Clinical Landscape Report 2026
15 October 2026
NCT05951205 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Leramistat in Idiopathic Pulmonary Fibrosis: NCT05951296 Clinical Landscape Report 2026
15 October 2026
NCT05951296 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ambroxol Hydrochloride in Amyotrophic Lateral Sclerosis: NCT05959850 Clinical Landscape Report 2026
15 October 2026
NCT05959850 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LTI-03 in Idiopathic Pulmonary Fibrosis: NCT05954988 Clinical Landscape Report 2026
15 October 2026
NCT05954988 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Idiopathic Pulmonary Fibrosis: NCT05976217 Clinical Landscape Report 2026
15 October 2026
NCT05976217 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nalbuphine Hydrochloride in Cough: NCT05964335 Clinical Landscape Report 2026
15 October 2026
NCT05964335 clinical landscape for Cough: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Itopride Hydrochloride in Metabolic Dysfunction Associated Steatohepatitis: NCT05966025 Clinical Landscape Report 2026
15 October 2026
NCT05966025 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
![[89Zr]Zr-DFO-APAC in Amyotrophic Lateral Sclerosis: NCT05974579 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_B_86_48077a7b89.jpg)
9 min read
[89Zr]Zr-DFO-APAC in Amyotrophic Lateral Sclerosis: NCT05974579 Clinical Landscape Report 2026
15 October 2026
NCT05974579 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HU-6 in Metabolic Dysfunction Associated Steatohepatitis: NCT05979779 Clinical Landscape Report 2026
15 October 2026
NCT05979779 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Rentosertib in Idiopathic Pulmonary Fibrosis: NCT05975983 Clinical Landscape Report 2026
15 October 2026
NCT05975983 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
FC-12738 in Amyotrophic Lateral Sclerosis: NCT05978908 Clinical Landscape Report 2026
15 October 2026
NCT05978908 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bicalutamide in Metabolic Dysfunction Associated Steatohepatitis: NCT05979389 Clinical Landscape Report 2026
15 October 2026
NCT05979389 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…